{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:55:38Z","timestamp":1777661738028,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/dmd.122.001133","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T21:45:13Z","timestamp":1683150313000},"page":"970-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis"],"prefix":"10.1016","volume":"51","author":[{"given":"Kayla L.","family":"Frost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4215-9434","authenticated-orcid":false,"given":"Joseph L.","family":"Jilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica L.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Goedken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.122.001133_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/dmd.122.001133_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.122.001133_bib3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/dmd.113.055996","article-title":"Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models","volume":"42","author":"Canet","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib4","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.2337\/db14-1947","article-title":"Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis","volume":"64","author":"Clarke","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/dmd.122.001133_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ckj\/sfw070","article-title":"Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?","volume":"9","author":"Delanaye","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1124\/dmd.122.001133_bib6","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3390\/ijms21165737","article-title":"Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract","volume":"21","author":"Dro\u017adzik","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.122.001133_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22035","article-title":"Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis","volume":"32","author":"Dzierlenga","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/dmd.122.001133_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and\/or Toxicity of Drugs: A White Paper From the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001133_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/toxsci\/kfac070","article-title":"Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination","volume":"189","author":"Frost","year":"2022","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.122.001133_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/dmd.122.001038","article-title":"Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination","volume":"51","author":"Frost","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfu156","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","volume":"142","author":"Hardwick","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.122.001133_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/dmd.111.041095","article-title":"Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis","volume":"40","author":"Hardwick","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib14","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.apsb.2021.05.030","article-title":"Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity","volume":"11","author":"Jilek","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.122.001133_bib15","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/dmd.121.000451","article-title":"Attenuated Ochratoxin A Transporter Expression in a Mouse Model of Nonalcoholic Steatohepatitis Protects against Proximal Convoluted Tubule Toxicity","volume":"50","author":"Jilek","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bcp.2016.07.001","article-title":"Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir","volume":"115","author":"Laho","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.001133_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/dmd.122.001133_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.116.074294","article-title":"Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach","volume":"45","author":"Mathialagan","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1124\/dmd.122.001133_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172913","article-title":"Challenges and opportunities in drug development for nonalcoholic steatohepatitis","volume":"870","author":"Ocker","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.122.001133_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1124\/dmd.122.001133_bib22","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/dmd.122.001133_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113780","article-title":"Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance","volume":"174","author":"Toth","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.001133_bib24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1124\/dmd.118.082081","article-title":"Gene-by-Environment Interaction of Bcrp-\/- and Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition","volume":"46","author":"Toth","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001133_bib25","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13205","article-title":"Validation of a routine two-sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD","volume":"5","author":"Turner","year":"2017","journal-title":"Physiol Rep"},{"key":"10.1124\/dmd.122.001133_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cpt.1699","article-title":"Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease","volume":"107","author":"Vildhede","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001133_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.122.001133_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cld.710","article-title":"The epidemiology of nonalcoholic steatohepatitis","volume":"11","author":"Younossi","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1124\/dmd.122.001133_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.122.001133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:03:26Z","timestamp":1739955806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624010225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0090955624010225"],"URL":"https:\/\/doi.org\/10.1124\/dmd.122.001133","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.122.001133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}